Keynote Financial Services LLC Takes $81,000 Position in Celularity Inc. (NASDAQ:CELU)

Keynote Financial Services LLC acquired a new stake in Celularity Inc. (NASDAQ:CELU) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 15,566 shares of the company’s stock, valued at approximately $81,000. Keynote Financial Services LLC owned approximately 0.08% of Celularity as of its most recent SEC filing.

Celularity Stock Performance

Shares of NASDAQ:CELU traded down $0.12 during mid-day trading on Friday, hitting $3.03. The company had a trading volume of 9,496 shares, compared to its average volume of 15,535. The firm has a fifty day moving average price of $3.08 and a 200 day moving average price of $3.75. Celularity Inc. has a one year low of $1.59 and a one year high of $7.97.

Celularity Company Profile

Celularity Inc, a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, an allogeneic CAR-T cell for the treatment of non-Hodkin's lymphoma (NHL) and mantle cell lymphoma (MCL); CYNK-001, an allogeneic unmodified natural killer cell that is in Phase I/II clinical trial for the treatment of acute myeloid leukemia (AML); and APPL-001, a genetically modified placental-derived mesenchymal-like adherent stromal cell for the treatment of Crohn's disease.